Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Glycerylphosphorylcholine
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease
Details : Choline Alfoscerate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Alzheimer Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 20, 2022
Lead Product(s) : Glycerylphosphorylcholine
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Glycerylphosphorylcholine
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Choline Alfoscerate Re-evaluation Consortium
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Choline Alfoscerate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Vascular Cognitive Impairment.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 20, 2021
Lead Product(s) : Glycerylphosphorylcholine
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Choline Alfoscerate Re-evaluation Consortium
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Glycerylphosphorylcholine
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Choline Alfoscerate Re-evaluation Consortium
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Choline Alfoscerate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Cognitive Dysfunction.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 13, 2021
Lead Product(s) : Glycerylphosphorylcholine
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Choline Alfoscerate Re-evaluation Consortium
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Glycerylphosphorylcholine
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia
Details : Choline Alfoscerate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Alzheimer Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 22, 2018
Lead Product(s) : Glycerylphosphorylcholine
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Glycerylphosphorylcholine
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Choline Alfoscerate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Alzheimer Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 07, 2016
Lead Product(s) : Glycerylphosphorylcholine
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable